Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Treasury Shares (2019 - 2025)

AVITA Medical (RCEL) has disclosed Treasury Shares for 4 consecutive years, with $67048.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Treasury Shares fell 42.79% year-over-year to $67048.0, compared with a TTM value of $67048.0 through Dec 2025, down 42.79%, and an annual FY2025 reading of $67048.0, down 42.79% over the prior year.
  • Treasury Shares was $67048.0 for Q4 2025 at AVITA Medical, roughly flat from $67048.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $461496.0 in Q3 2022 and bottomed at $67048.0 in Q3 2025.
  • Average Treasury Shares over 4 years is $231112.5, with a median of $217615.0 recorded in 2022.
  • The sharpest move saw Treasury Shares soared 71.35% in 2023, then crashed 56.05% in 2024.
  • Year by year, Treasury Shares stood at $460518.0 in 2022, then plummeted by 48.94% to $235132.0 in 2023, then crashed by 50.16% to $117196.0 in 2024, then crashed by 42.79% to $67048.0 in 2025.
  • Business Quant data shows Treasury Shares for RCEL at $67048.0 in Q4 2025, $67048.0 in Q3 2025, and $99504.0 in Q2 2025.